Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4137/CGast.S38451 http://scihub22266oqcxt.onion/10.4137/CGast.S38451 C4902039!4902039!27330336     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27330336.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Clin+Med+Insights+Gastroenterol 2016 ; 9 (ä): 25-9 Nephropedia Template TP {{tp|p=27330336|t=2016. Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management |pdf=|usr=}}{{27330336}} gab.com Text Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management JO: Clin Med Insights Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=27330336 #FOAvip Primary sclerosing cholangitis is a chronic immune-mediated liver disease. Though rare, it poses several clinical concerns for the managing physician. There are currently limited therapeutic options in the management of the condition and weak evidence base behind them. Endoscopic intervention is limited to those patients with obstructing stricture-related disease, and even liver transplantation has a risk of disease recurrence. Surveillance for inflammatory bowel disorders, metabolic bone disease, and malignancy is paramount when managing such patients. This article provides an overview of the condition with further focus on current therapeutic options and guidance on surveillance management. Twit Text FOAVip Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management ????Clin Med Insights Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=27330336 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27330336 #FOAvip English Wikipedia <ref>{{Cite pmid|27330336}}</ref> Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management #MMPMID27330336 Kumar A; Wheatley D; Puttanna A Clin Med Insights Gastroenterol 2016[]; 9 (ä): 25-9 PMID27330336show ga Primary sclerosing cholangitis is a chronic immune-mediated liver disease. Though rare, it poses several clinical concerns for the managing physician. There are currently limited therapeutic options in the management of the condition and weak evidence base behind them. Endoscopic intervention is limited to those patients with obstructing stricture-related disease, and even liver transplantation has a risk of disease recurrence. Surveillance for inflammatory bowel disorders, metabolic bone disease, and malignancy is paramount when managing such patients. This article provides an overview of the condition with further focus on current therapeutic options and guidance on surveillance management. äPrimary Sclerosing Cholangitis: Therapeutic Options and Surveillance M(epmc).pdf DeepDyve Pubget Overpricing